Endometrial Cancer

Flash Player is required to view this video.

CancerSmart Web Cast

May 3, 2007 -- Drs. Carol Brown, Nadeem Abu-Rustum, and Paul Sabbatini present, "What You Should Know About the Screening and Treatment of Gynecologic Cancers."
Run time: 71 minutes.

Endometrial cancer, the most common gynecologic cancer in the United States today, originates in the lining of the uterus, known as the endometrium. This kind of cancer is diagnosed in more than 39,500 women every year. Endometrial cancer is often found at its earliest, most curable stages by women who notice abnormal vaginal bleeding.

In this section, you can find information about our expertise in treating women with endometrial cancer, our services, and our research.

Overview
Endometrial cancer is the most common tumor of the female reproductive system. Because it is often found early, it can frequently be cured.
Risk Factors
Any factor that increases a woman's exposure to estrogen over time leads to an increased risk of endometrial cancer. Obesity, early menstruation, tamoxifen use, hormone replacement therapy, family history, and endometrial hyperplasia can also be factors.
Symptoms
The most common symptom of endometrial cancer is postmenopausal bleeding or irregular vaginal bleeding.
Diagnosis
Transvaginal ultrasound (in which a special imaging wand is inserted into the vagina to identify tumors) and endometrial biopsy are the tests most commonly performed to diagnose endometrial cancer.
Treatment
For most women with endometrial cancer, surgery is the primary form of treatment. Others may also need radiation therapy, hormone therapy, and/or chemotherapy.
Survivorship & Support
When endometrial cancer is discovered in its earliest, most treatable stages, most patients are completely cured.

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org